New minimally invasive therapy shows promise for liver cancer patients
New Delhi, Dec 26 (IANS) A new minimally invasive therapy has shown promise and may benefit patients with hepatocellular carcinoma (HCC) -- the most common type of primary liver cancer -- in India.
Globocan India 2020 reports more…
Read More...
Read More...